Correlation Between Zentalis Pharmaceuticals and Nuvalent

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Zentalis Pharmaceuticals and Nuvalent at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Zentalis Pharmaceuticals and Nuvalent into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Zentalis Pharmaceuticals Llc and Nuvalent, you can compare the effects of market volatilities on Zentalis Pharmaceuticals and Nuvalent and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Zentalis Pharmaceuticals with a short position of Nuvalent. Check out your portfolio center. Please also check ongoing floating volatility patterns of Zentalis Pharmaceuticals and Nuvalent.

Diversification Opportunities for Zentalis Pharmaceuticals and Nuvalent

0.29
  Correlation Coefficient

Modest diversification

The 3 months correlation between Zentalis and Nuvalent is 0.29. Overlapping area represents the amount of risk that can be diversified away by holding Zentalis Pharmaceuticals Llc and Nuvalent in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nuvalent and Zentalis Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Zentalis Pharmaceuticals Llc are associated (or correlated) with Nuvalent. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nuvalent has no effect on the direction of Zentalis Pharmaceuticals i.e., Zentalis Pharmaceuticals and Nuvalent go up and down completely randomly.

Pair Corralation between Zentalis Pharmaceuticals and Nuvalent

Given the investment horizon of 90 days Zentalis Pharmaceuticals Llc is expected to generate 3.59 times more return on investment than Nuvalent. However, Zentalis Pharmaceuticals is 3.59 times more volatile than Nuvalent. It trades about 0.06 of its potential returns per unit of risk. Nuvalent is currently generating about 0.04 per unit of risk. If you would invest  310.00  in Zentalis Pharmaceuticals Llc on August 25, 2024 and sell it today you would earn a total of  13.00  from holding Zentalis Pharmaceuticals Llc or generate 4.19% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Zentalis Pharmaceuticals Llc  vs.  Nuvalent

 Performance 
       Timeline  
Zentalis Pharmaceuticals 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Zentalis Pharmaceuticals Llc are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite quite weak basic indicators, Zentalis Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in December 2024.
Nuvalent 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Nuvalent are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite quite unfluctuating basic indicators, Nuvalent disclosed solid returns over the last few months and may actually be approaching a breakup point.

Zentalis Pharmaceuticals and Nuvalent Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Zentalis Pharmaceuticals and Nuvalent

The main advantage of trading using opposite Zentalis Pharmaceuticals and Nuvalent positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Zentalis Pharmaceuticals position performs unexpectedly, Nuvalent can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nuvalent will offset losses from the drop in Nuvalent's long position.
The idea behind Zentalis Pharmaceuticals Llc and Nuvalent pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Other Complementary Tools

Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Transaction History
View history of all your transactions and understand their impact on performance
Stocks Directory
Find actively traded stocks across global markets
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA